MedPath

Tolterodine

Generic Name
Tolterodine
Brand Names
Detrol, Detrusitol
Drug Type
Small Molecule
Chemical Formula
C22H31NO
CAS Number
124937-51-5
Unique Ingredient Identifier
WHE7A56U7K

Overview

Tolterodine is an antimuscarinic drug that is used to treat urinary incontinence. Tolterodine acts on M2 and M3 subtypes of muscarinic receptors.

Background

Tolterodine is an antimuscarinic drug that is used to treat urinary incontinence. Tolterodine acts on M2 and M3 subtypes of muscarinic receptors.

Indication

For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).

Associated Conditions

  • Urinary Urge Incontinence

FDA Approved Products

Detrol
Manufacturer:PHARMACIA & UPJOHN COMPANY LLC
Route:ORAL
Strength:2 mg in 1 1
Approved: 2021/09/29
NDC:0009-4544
Detrol
Manufacturer:PHARMACIA & UPJOHN COMPANY LLC
Route:ORAL
Strength:1 mg in 1 1
Approved: 2021/09/29
NDC:0009-4541
TOLTERODINE TARTRATE
Manufacturer:Major Pharmaceuticals
Route:ORAL
Strength:4 mg in 1 1
Approved: 2019/11/13
NDC:0904-6593
Tolterodine Tartrate
Manufacturer:Teva Pharmaceuticals USA, Inc.
Route:ORAL
Strength:1 mg in 1 1
Approved: 2022/10/11
NDC:0093-0010
Tolterodine Tartrate
Manufacturer:ANI Pharmaceuticals, Inc.
Route:ORAL
Strength:2 mg in 1 1
Approved: 2020/02/01
NDC:43975-322

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath